TrialJournal of human hypertension2004
Disparate systemic and renal blocking properties of angiotensin II antagonists during exogenous angiotensin II administration: implications for treatment.
J M Willemsen et al.PubMed ↗Publisher ↗
No numbers read from the abstract.